Conference Coverage: EHA Congress 2012

Cancer Patients Differ With Docs on QoL Issues

Publish date: August 6, 2012

Publish date: July 12, 2012

Major Finding: In the nilotinib-treated group, 96.9% of those who achieved BCR-ABL transcript levels of 1% or less and 98.8% of those who achieved...

Publish date: July 9, 2012

Publish date: June 29, 2012

Major Finding: Crude prevalences of CNS involvement at diagnosis and overall were 0.9% and 4.1%, respectively, with a median time to an event of...

Publish date: June 29, 2012

Major Finding: After multivariate adjustment, 3-year EFS, PFS, and OS were no different in patients who had received radiotherapy for bulky...

Publish date: June 26, 2012

Publish date: June 20, 2012

Publish date: June 19, 2012

Major Finding: Eight of nine patients responded to crizotinib, and four had durable responses lasting more than 6 months.Data Source: Nine adults...